CA3172777A1 - Compositions for colon cleansing and the treatment of gastrointestinal disorders - Google Patents

Compositions for colon cleansing and the treatment of gastrointestinal disorders

Info

Publication number
CA3172777A1
CA3172777A1 CA3172777A CA3172777A CA3172777A1 CA 3172777 A1 CA3172777 A1 CA 3172777A1 CA 3172777 A CA3172777 A CA 3172777A CA 3172777 A CA3172777 A CA 3172777A CA 3172777 A1 CA3172777 A1 CA 3172777A1
Authority
CA
Canada
Prior art keywords
cys
seq
tyr
leu
asn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3172777A
Other languages
English (en)
French (fr)
Inventor
Mark G. Currie
Robert SOLINGA
Christopher Leitheiser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ironwood Pharmaceuticals Inc
Original Assignee
Ironwood Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ironwood Pharmaceuticals Inc filed Critical Ironwood Pharmaceuticals Inc
Publication of CA3172777A1 publication Critical patent/CA3172777A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA3172777A 2015-05-01 2016-04-29 Compositions for colon cleansing and the treatment of gastrointestinal disorders Pending CA3172777A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562156077P 2015-05-01 2015-05-01
US62/156,077 2015-05-01
CA2984437A CA2984437C (en) 2015-05-01 2016-04-29 COMPOSITION FOR COLON CLEANSING AND THE TREATMENT OF GASTROINTESTINAL DISORDERS

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA2984437A Division CA2984437C (en) 2015-05-01 2016-04-29 COMPOSITION FOR COLON CLEANSING AND THE TREATMENT OF GASTROINTESTINAL DISORDERS

Publications (1)

Publication Number Publication Date
CA3172777A1 true CA3172777A1 (en) 2016-11-10

Family

ID=55953439

Family Applications (2)

Application Number Title Priority Date Filing Date
CA2984437A Active CA2984437C (en) 2015-05-01 2016-04-29 COMPOSITION FOR COLON CLEANSING AND THE TREATMENT OF GASTROINTESTINAL DISORDERS
CA3172777A Pending CA3172777A1 (en) 2015-05-01 2016-04-29 Compositions for colon cleansing and the treatment of gastrointestinal disorders

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CA2984437A Active CA2984437C (en) 2015-05-01 2016-04-29 COMPOSITION FOR COLON CLEANSING AND THE TREATMENT OF GASTROINTESTINAL DISORDERS

Country Status (23)

Country Link
US (2) US10618938B2 (enExample)
EP (2) EP3288578B8 (enExample)
JP (5) JP6930919B2 (enExample)
KR (2) KR102783759B1 (enExample)
CN (2) CN114716514A (enExample)
CA (2) CA2984437C (enExample)
CY (1) CY1126031T1 (enExample)
DK (1) DK3288578T5 (enExample)
EA (1) EA201792401A1 (enExample)
ES (1) ES2947591T3 (enExample)
FI (1) FI3288578T3 (enExample)
HR (1) HRP20230381T1 (enExample)
HU (1) HUE061954T2 (enExample)
LT (1) LT3288578T (enExample)
MA (1) MA41985B1 (enExample)
MD (1) MD3288578T2 (enExample)
MX (2) MX2017013928A (enExample)
PL (1) PL3288578T3 (enExample)
PT (1) PT3288578T (enExample)
RS (1) RS64160B1 (enExample)
SI (1) SI3288578T1 (enExample)
SM (1) SMT202300114T1 (enExample)
WO (1) WO2016178979A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SMT202300114T1 (it) * 2015-05-01 2023-05-12 Ironwood Pharmaceuticals Inc Composizioni per la pulizia del colon e il trattamento di disturbi gastrointestinali.
SMT202200173T1 (it) 2016-06-01 2022-05-12 Athira Pharma Inc Composti
CA3238636A1 (en) * 2021-11-24 2023-06-01 Christopher Leitheiser Synthetic process for production of modified gcc receptor agonists
AU2022396412A1 (en) * 2021-11-24 2024-05-30 Ironwood Pharmaceuticals, Inc. Synthetic process for production of modified gcc receptor agonists
IL313184A (en) 2021-11-29 2024-07-01 Ironwood Pharmaceuticals Inc Pharmaceutical compositions for the treatment of visceral pain

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH689139A5 (de) 1995-04-03 1998-10-30 Cerbios Pharma Sa Verfahren zur Herstellung einer liposomalen, in Wasser dispergierbaren, oral zu verabreichenden, festen, trockenen therapeutischen Formulierung.
US5912014A (en) 1996-03-15 1999-06-15 Unigene Laboratories, Inc. Oral salmon calcitonin pharmaceutical products
DK1594517T3 (da) * 2003-01-28 2007-10-29 Microbia Inc Sammensætninger til behandlingen af gastrointestinale lidelser
US7494979B2 (en) * 2003-06-13 2009-02-24 Ironwood Pharmaceuticals, Inc. Method for treating congestive heart failure and other disorders
CA2619650A1 (en) * 2005-08-19 2007-02-22 Microbia, Inc. Methods and compositions for the treatment of gastrointestinal disorders
WO2010025510A1 (en) * 2008-09-03 2010-03-11 Xenome Ltd Libraries of peptide conjugates and methods for making them
DK2536742T3 (en) * 2010-02-17 2017-09-04 Ironwood Pharmaceuticals Inc TREATMENTS FOR GASTROINTESTINAL DISORDERS
CN103764672A (zh) * 2011-03-01 2014-04-30 辛纳吉制药公司 制备鸟苷酸环化酶c激动剂的方法
JP6499591B2 (ja) * 2013-02-25 2019-04-10 シナジー ファーマシューティカルズ インコーポレイテッド 結腸洗浄において用いるためのグアニル酸シクラーゼ受容体アゴニスト
BR112015030326A2 (pt) * 2013-06-05 2017-08-29 Synergy Pharmaceuticals Inc Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos
WO2016015055A1 (en) * 2014-07-25 2016-01-28 Ironwood Pharmaceuticals, Inc. Colon cleansing compositions
SMT202300114T1 (it) * 2015-05-01 2023-05-12 Ironwood Pharmaceuticals Inc Composizioni per la pulizia del colon e il trattamento di disturbi gastrointestinali.

Also Published As

Publication number Publication date
MA41985B1 (fr) 2023-04-28
HRP20230381T1 (hr) 2023-07-07
JP2024015335A (ja) 2024-02-01
US10618938B2 (en) 2020-04-14
DK3288578T3 (da) 2023-05-01
CY1126031T1 (el) 2023-11-15
BR112017023539A2 (pt) 2018-08-14
CA2984437C (en) 2025-11-18
EP3288578B8 (en) 2023-03-29
EP3288578A1 (en) 2018-03-07
MD3288578T2 (ro) 2023-08-31
WO2016178979A1 (en) 2016-11-10
DK3288578T5 (da) 2024-10-07
MX2022013283A (es) 2022-12-13
EA201792401A1 (ru) 2018-05-31
HUE061954T2 (hu) 2023-09-28
KR102783759B1 (ko) 2025-03-21
EP3288578B1 (en) 2023-03-15
JP6930919B2 (ja) 2021-09-01
RS64160B1 (sr) 2023-05-31
KR20180005675A (ko) 2018-01-16
MA41985A (fr) 2018-03-07
MX2017013928A (es) 2018-01-15
JP2018519254A (ja) 2018-07-19
LT3288578T (lt) 2023-04-25
CA2984437A1 (en) 2016-11-10
JP2022121734A (ja) 2022-08-19
JP2025169325A (ja) 2025-11-12
SI3288578T1 (sl) 2023-07-31
PL3288578T3 (pl) 2023-08-14
PT3288578T (pt) 2023-03-28
CN108040482A (zh) 2018-05-15
ES2947591T3 (es) 2023-08-11
CN114716514A (zh) 2022-07-08
KR20250042844A (ko) 2025-03-27
JP2020203954A (ja) 2020-12-24
EP4218789A3 (en) 2023-09-27
SMT202300114T1 (it) 2023-05-12
EP4218789A2 (en) 2023-08-02
FI3288578T3 (fi) 2023-05-03
CN108040482B (zh) 2022-03-29
US20240199697A1 (en) 2024-06-20
US20180148476A1 (en) 2018-05-31

Similar Documents

Publication Publication Date Title
AU2010314866B2 (en) Treatments for gastrointestinal disorders
US20240199697A1 (en) Compositions for Colon Cleansing and the Treatment of Gastrointestinal Disorders
EP2509992B1 (en) Treatments for gastrointestinal disorders
AU2011218009B2 (en) Treatments for gastrointestinal disorders
CA2846230A1 (en) Treatments for gastrointestinal disorders
CA2835624A1 (en) Treatments for gastrointestinal disorders
HK40097176A (en) Compositions for colon cleansing and the treatment of gastrointestnal disorders
HK40080323A (en) Compositions for colon cleansing and the treatment of gastrointestinal disorders
EA048992B1 (ru) Композиции для очищения толстого кишечника и лечения желудочно-кишечных расстройств
BR112017023539B1 (pt) Peptídeos ou sais farmaceuticamente aceitáveis do mesmo, seus métodos de produção, seus usos e composições farmaceuticas

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20220902

EEER Examination request

Effective date: 20220902

EEER Examination request

Effective date: 20220902

EEER Examination request

Effective date: 20220902

EEER Examination request

Effective date: 20220902

EEER Examination request

Effective date: 20220902

EEER Examination request

Effective date: 20220902

EEER Examination request

Effective date: 20220902